Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7452 | 1286 | 49.3 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
989 | 10020 | CHRONIC MYELOID LEUKEMIA//IMATINIB//BCR ABL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | C ABL | Author keyword | 40 | 41% | 6% | 76 |
2 | BCR ABL | Author keyword | 27 | 14% | 14% | 179 |
3 | BCR ABL ONCOPROTEIN | Author keyword | 15 | 82% | 1% | 9 |
4 | ABELSON MURINE LEUKEMIA VIRUS | Author keyword | 11 | 78% | 1% | 7 |
5 | RIN1 | Author keyword | 10 | 58% | 1% | 11 |
6 | V ABL | Author keyword | 8 | 56% | 1% | 10 |
7 | ARG TYROSINE KINASE | Author keyword | 6 | 80% | 0% | 4 |
8 | ABL KINASES | Author keyword | 6 | 100% | 0% | 4 |
9 | ABL | Author keyword | 5 | 15% | 2% | 31 |
10 | P210 BCR ABL | Author keyword | 5 | 63% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | C ABL | 40 | 41% | 6% | 76 | Search C+ABL | Search C+ABL |
2 | BCR ABL | 27 | 14% | 14% | 179 | Search BCR+ABL | Search BCR+ABL |
3 | BCR ABL ONCOPROTEIN | 15 | 82% | 1% | 9 | Search BCR+ABL+ONCOPROTEIN | Search BCR+ABL+ONCOPROTEIN |
4 | ABELSON MURINE LEUKEMIA VIRUS | 11 | 78% | 1% | 7 | Search ABELSON+MURINE+LEUKEMIA+VIRUS | Search ABELSON+MURINE+LEUKEMIA+VIRUS |
5 | RIN1 | 10 | 58% | 1% | 11 | Search RIN1 | Search RIN1 |
6 | V ABL | 8 | 56% | 1% | 10 | Search V+ABL | Search V+ABL |
7 | ARG TYROSINE KINASE | 6 | 80% | 0% | 4 | Search ARG+TYROSINE+KINASE | Search ARG+TYROSINE+KINASE |
8 | ABL KINASES | 6 | 100% | 0% | 4 | Search ABL+KINASES | Search ABL+KINASES |
9 | ABL | 5 | 15% | 2% | 31 | Search ABL | Search ABL |
10 | P210 BCR ABL | 5 | 63% | 0% | 5 | Search P210+BCR+ABL | Search P210+BCR+ABL |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | V ABL | 72 | 56% | 7% | 88 |
2 | C ABL | 60 | 21% | 19% | 248 |
3 | POSITIVE HUMAN LEUKEMIAS | 50 | 81% | 2% | 30 |
4 | BCR ABL ONCOGENE | 35 | 41% | 5% | 67 |
5 | PHILADELPHIA CHROMOSOME | 34 | 13% | 19% | 250 |
6 | P210 BCR ABL | 18 | 58% | 2% | 21 |
7 | GENE ARG | 11 | 100% | 0% | 6 |
8 | LYMPHOID CELL TRANSFORMATION | 11 | 100% | 0% | 6 |
9 | FACTOR DEPENDENT CELLS | 10 | 73% | 1% | 8 |
10 | GROWTH FACTOR INDEPENDENCE | 10 | 42% | 1% | 18 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Role of ABL family kinases in cancer: from leukaemia to solid tumours | 2013 | 37 | 148 | 37% |
Regulation of the C-Abl and Bcr-Abl tyrosine kinases | 2004 | 210 | 91 | 52% |
ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity | 2010 | 60 | 239 | 44% |
Structure and Dynamic Regulation of Abl Kinases | 2013 | 15 | 67 | 45% |
The Abl family kinases: Mechanisms of regulation and signaling | 2002 | 169 | 165 | 54% |
Cycling, stressed-out and nervous: cellular functions of c-Abl | 1999 | 207 | 60 | 62% |
How do Abl family kinases regulate cell shape and movement? | 2004 | 110 | 66 | 65% |
The BCR-ABL story: Bench to bedside and back | 2004 | 205 | 321 | 36% |
Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells | 2008 | 60 | 102 | 42% |
Targeting Abl Kinases to Regulate Vascular Leak During Sepsis and Acute Respiratory Distress Syndrome | 2015 | 1 | 77 | 35% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN CYTOBIOL | 4 | 67% | 0.3% | 4 |
2 | IST EMATOL ONCOL MED LORENZO ARIOSTO SERAGNOL | 4 | 67% | 0.3% | 4 |
3 | MOL BIOL INTERDEPARTMENTAL PHD PROGRAM | 4 | 75% | 0.2% | 3 |
4 | LEUKAEMIA FUND CELLULAR DEV UNIT | 4 | 46% | 0.5% | 6 |
5 | MOL MICROBIOL PROGRAM | 2 | 50% | 0.2% | 3 |
6 | TRANSLAT CELL THER Y | 2 | 33% | 0.4% | 5 |
7 | IST RADIOTER IA LUIGI GALVANI | 2 | 36% | 0.3% | 4 |
8 | METABOL PROTE CALIF NANOSYST | 1 | 100% | 0.2% | 2 |
9 | MOL BIOL JONSSON COMPREHENS CANC | 1 | 50% | 0.2% | 2 |
10 | MOL BIOLDIABET | 1 | 50% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000167129 | CHRONIC MYELOID LEUKEMIA//IMATINIB//NILOTINIB |
2 | 0.0000156881 | PHILADELPHIA CHROMOSOME//CML//CHRONIC MYELOGENOUS LEUKEMIA |
3 | 0.0000128974 | NEDD9//HEF1//CRK |
4 | 0.0000099684 | C FES//FER KINASE//FPS FES |
5 | 0.0000074663 | C FGR//TYROSINE PROTEIN KINASE//CSK |
6 | 0.0000069638 | GRB2//SH2 DOMAIN//SH3 DOMAIN |
7 | 0.0000064370 | EXPTL IMMUNOL UNIT//BN 52080//GLUCOCORTICOIDS SYNTHETIC |
8 | 0.0000060263 | GM CSF RECEPTOR//BLAST COLONIES//COMMON BETA SUBUNIT |
9 | 0.0000050842 | CBL B//CBL//CIN85 |
10 | 0.0000045826 | V ERB B//V ERBB//ACUTE RETROVIRUS |